Heidelberg Pharma AG
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma (NCT04879043) | Heidelberg Pharma AG | 2022-02-07 |
| REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT (NCT01762592) | Heidelberg Pharma AG | 2017-12-01 |
Track Heidelberg Pharma AG automatically
Every clearance here is in the API, with alerts when new ones post.